Initially projected (in late April) to complete enriollment in 3-4 months (so May-Aug). Q4 now suggests it won't even be this month.
Back pain and heart also delayed beyond initial guidance (that was reiterated mid-year).
I've heard it said (from ecool2 I think) that MSB are conservative in their guidance but almost always meet theit timlines. Not recently.
That's not a criticism, it is what it is, and #covid, but it's still annoying.
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-46
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |